A Double-Blind, Randomized, Placebo-Controlled Trial To Evaluate The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes
Phase of Trial: Phase II
Latest Information Update: 28 Sep 2017
At a glance
- Drugs Immune globulin (Primary) ; Albumins
- Indications Diabetic neuropathies; Neurogenic pain
- Focus Therapeutic Use
- 22 Sep 2017 Status changed from not yet recruiting to recruiting.
- 11 Jul 2017 Planned initiation date changed from 1 Jul 2017 to 1 Sep 2017.
- 17 May 2017 Planned initiation date changed from 1 May 2017 to 1 Jul 2017.